Qiagen LLC DNA Isolation Kits

Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
State: Maryland
Type of Government: Federal
FSC Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
NAICS Category:
  • 325413 - In-Vitro Diagnostic Substance Manufacturing
Posted Date: Oct 21, 2024
Due Date: Oct 31, 2024
Solicitation No: 25-000010
Original Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page

Description

Follow
Qiagen LLC DNA Isolation Kits
Active
Contract Opportunity
Notice ID
25-000010
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH - CC
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information
  • Contract Opportunity Type: Presolicitation (Original)
  • Original Published Date: Oct 21, 2024 07:58 am EDT
  • Original Response Date: Oct 31, 2024 06:30 am EDT
  • Inactive Policy: Manual
  • Original Inactive Date: Nov 01, 2024
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
  • NAICS Code:
    • 325413 - In-Vitro Diagnostic Substance Manufacturing
  • Place of Performance:
    Bethesda , MD 20892
    USA
Description

Title



Qiagen LLC DNA Isolation Kits








  • Product Service Code: 6550

  • NAICS Code: 325413

  • Place of Performance:



Bethesda, MD 20892 USA







POTS: 25-000010





Description





This is a notice of intent, NOT a request for a quotation. A solicitation document will NOT be issued, and quotations will NOT be requested.





The National Institutes of Health (NIH) plans to issue a firm fixed-price purchase order to Qiagen LLC located in Germantown Maryland 20874-1415, on a sole source basis. The purpose of this acquisition is to purchase DNA Isolation Kits for the Human Leukocyte Antigen (HLA) Lab.





The HLA Laboratory offers both high and low-resolution HLA typing for patients at the NIH Clinical Center, often serving critically ill individuals. These testing kits have been rigorously tested by the HLA Lab to ensure the highest quality DNA samples for downstream testing. This contract will facilitate the shipment of testing kits on an as-needed basis throughout the year, preventing any risk of running out.



The quantity of kits procured is anticipated to meet the lab's needs for one year, based on current usage rates. The HLA Lab specifically requires Qiagen DNA isolation kits, as the lab's existing instrumentation is compatible only with these kits. Both the instrumentation and kits have undergone Quality Control testing by the HLA Lab, demonstrating their ability to produce the high-quality DNA necessary for Next Generation Sequencing testing mandated by CC clinicians. Using an inferior product could significantly impact the turnaround time for HLA typing results, potentially delaying lifesaving transplants.





The below items are required for this action:



Quantity/Catalog #/Item



1/1002137/Freight



60/951054/EZ1 & 2 DNA Blood 350 Kit (48)



6/953034/ EZ1 & 2 DNA Tissue Kit (48)





The proposed vendor, Qiagen LLC, is the exclusive manufacturer of the DNA isolation kits. There are no known vendors that can provide these specific reagents.



This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.



Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.





Comments to this announcement, referencing this posting number, may be submitted to the Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Shasheshe Goolsby, Lead Contract Specialist, shasheshe.goolsby@nih.gov by October 31, 2024, 6:30AM EST.



*** Please send your capability statements ONLY. This IS NOT a request for proposal. ***




Attachments/Links
Contact Information
Contracting Office Address
  • 6707 DEMOCRACY BLVD, SUITE 106
  • BETHESDA , MD 20892
  • USA
Primary Point of Contact
Secondary Point of Contact


History
  • Oct 21, 2024 07:58 am EDTPresolicitation (Original)
Get Government Bids Like This by Email Receive daily bid alerts that match your keywords, business categories, and target regions.

See Also

Follow Equipment : MRIs System Upgrade Active Contract Opportunity Notice ID 75N98026Q01246 Related

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Due by 9/23/2026

Follow BPA - X-RAY FILM AND SUPPLIES PSC 6525 Active Contract Opportunity Notice

DEPT OF DEFENSE

Due by 11/11/2028

Project Name Documents Deadline Ocean City Racquet Center Renovation Advertisement PDF Bid Document

City of Ocean

Due by 9/28/2026

Follow Request for Information - Automation Dispensing System and Pill Packager IDIQ Active

VETERANS AFFAIRS, DEPARTMENT OF

Due by 9/24/2026

* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.